Duration of Targeted Therapy in Patients With Advanced Non–small-cell Lung Cancer Identified by Circulating Tumor DNA Analysis-Reference-Cited by-同舟云学术

Duration of Targeted Therapy in Patients With Advanced Non–small-cell Lung Cancer Identified by Circulating Tumor DNA Analysis

Published:2020-11 Issue:6 Volume:21 Page:545-552.e1
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Reckamp Karen L.^ORCID,Patil Tejas^ORCID,Kirtane Kedar,Rich Thereasa A.^ORCID,Espenschied Carin R.^ORCID,Weipert Caroline M.,Raymond Victoria M.,Santana-Davila Rafael,Doebele Robert C.,Baik Christina S.

Funder

AbbVie

Acea

Adaptimmune

Boehringer Ingelheim

Bristol Myers Squibb

Genentech

GlaxoSmithKline

Guardant Health

Janssen

Loxo Oncology

Molecular Partners

Seattle Genetics

Spectrum

Takeda

Xcovery

Zeno

NRG Oncology

Merck

Pfizer

Bristol-Myers Squibb

F. Hoffman La Roche

Stemcentrx

BeyondSpring Pharmaceuticals

Dynavax Technologies

ALX Oncology

Abbvie

AstraZeneca

ISA Pharmaceuticals

Novartis

Genetech Inc

Spectrum Pharmaceuticals

Blueprint Medicines

Daiichi-Sankyo

Rain Therapeutics

TP Therapeutics

National Institutes of Health

National Cancer Institute

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference51 articles.

1. Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors;Lindeman;J Thorac Oncol,2018

2. Efficacy of larotrectinib in TRK fusion–positive cancers in adults and children;Drilon;N Engl J Med,2018

3. Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials;Doebele;Lancet Oncol,2020

4. Crizotinib in ROS1-rearranged non–small-cell lung cancer;Shaw;N Engl J Med,2014

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pan-Tumor Analytical Validation and Osimertinib Clinical Validation in EGFR Mutant Non–Small-Cell Lung Cancer, Supporting the First Next-Generation Sequencing Liquid Biopsy in Vitro Diagnostic;The Journal of Molecular Diagnostics;2024-01

2. Metastasis pattern and prognosis of large cell neuroendocrine carcinoma: a population-based study;Journal of Cancer Research and Clinical Oncology;2023-07-27

3. The Utility of ctDNA in Lung Cancer Clinical Research and Practice: A Systematic Review and Meta-Analysis of Clinical Studies;Cancer Investigation;2023-06-18

4. Circulating tumor DNA (ctDNA) as a biomarker for lung cancer: Early detection, monitoring and therapy prediction;Tumor Biology;2023-05-26

5. Liquid Biopsies in Lung Cancer;Cancers;2023-02-23